To investigate the role of Cyclin E dosage in tumor growth, we induced the formation Yki + dPGC1-RNAi tumors in a Cyclin E heterozygous (+/−) background and analyzed whether reduced Cyclin E levels affected tumor development. The gene discussed is CCNE1; the disease is neoplasm.